Hepatitis C - Patients with Hepatitis C using more healthcare resources

Patients with Hepatitis C using more healthcare resources
EurekAlert! - Hepatology is available online via Wiley InterScience Chronic Hepatitis C virus (HCV) affects about 3 million people

Novelos Therapeutics Gets Green Light from FDA for Phase 3 Development in Lung Cancer
New Age Media Concepts - cancer and our second compound, NOV-205, targeting chronic hepatitis C.' ' We are pleased that the FDA has considered

Decreased Prevalence of Steatosis after Treatment for Chronic Hepatitis C in HIV-HCV Coinfected Subjects
HIV and Hepatitis.com - By Marina Nunez, MD Factors associated with hepatic steatosis in HIV/HCV-coinfected patients concerning its influence on response to treatment are not clear.

FDA Grants Fast Track Designation to Vertex's Investigational Oral Hepatitis C Virus Protease Inhibitor VX-950
PR Newswire - CAMBRIDGE, Mass., Dec. 8 /PRNewswire-FirstCall/ -- Vertex PharmaceuticalsIncorporated (Nasdaq: VRTX) today announced that the U.S. Track designation to VX-950for the following reasons: * Chronic hepatitis C virus infection is a serious and life

Scientists Discover How a Hepatitis C Protein Promotes Liver Cancer
Newswise - Approximately 200 million people worldwide suffer from chronic hepatitis C, which can persist in the body for decades

ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels
Primezone Media Network - NYSE:WYE). In this trial, HCV-796 demonstrated antiviral effects in adult patients with chronic hepatitis C infection